skip to main content
Idioma:
previous page 1 2 Resultados 3 4 5 next page
Refinado por: Nome da Publicação: European Heart Journal remover
Result Number Material Type Add to My Shelf Action Record Details and Options
21
The ABC (age, biomarkers, clinical history) stroke risk score: a biomarker-based risk score for predicting stroke in atrial fibrillation
The ABC (age, biomarkers, clinical history) stroke risk score: a biomarker-based risk score for predicting stroke in atrial fibrillation
Material Type:
Artigo 		Adicionar ao Meu Espaço

The ABC (age, biomarkers, clinical history) stroke risk score: a biomarker-based risk score for predicting stroke in atrial fibrillation

Hijazi, Ziad ; Lindbäck, Johan ; Alexander, John H ; Hanna, Michael ; Held, Claes ; Hylek, Elaine M ; Lopes, Renato D ; Oldgren, Jonas ; Siegbahn, Agneta ; Stewart, Ralph A H ; White, Harvey D ; Granger, Christopher B ; Wallentin, Lars

European heart journal, 2016-05, Vol.37 (20), p.1582-1590 [Periódico revisado por pares]

England: Oxford University Press

Texto completo disponível

Citações Citado por
22
Outcomes of apixaban vs. warfarin by type and duration of atrial fibrillation: results from the ARISTOTLE trial
Outcomes of apixaban vs. warfarin by type and duration of atrial fibrillation: results from the ARISTOTLE trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Outcomes of apixaban vs. warfarin by type and duration of atrial fibrillation: results from the ARISTOTLE trial

Al-Khatib, Sana M ; Thomas, Laine ; Wallentin, Lars ; Lopes, Renato D ; Gersh, Bernard ; Garcia, David ; Ezekowitz, Justin ; Alings, Marco ; Yang, Hongqui ; Alexander, John H ; Flaker, Gregory ; Hanna, Michael ; Granger, Christopher B

European heart journal, 2013-08, Vol.34 (31), p.2464-2471 [Periódico revisado por pares]

England

Texto completo disponível

Citações Citado por
23
Effects of alirocumab on types of myocardial infarction: insights from the ODYSSEY OUTCOMES trial
Effects of alirocumab on types of myocardial infarction: insights from the ODYSSEY OUTCOMES trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Effects of alirocumab on types of myocardial infarction: insights from the ODYSSEY OUTCOMES trial

White, Harvey D ; Steg, Ph Gabriel ; Szarek, Michael ; Bhatt, Deepak L ; Bittner, Vera A ; Diaz, Rafael ; Edelberg, Jay M ; Erglis, Andrejs ; Goodman, Shaun G ; Hanotin, Corinne ; Harrington, Robert A ; Jukema, J Wouter ; Lopes, Renato D ; Mahaffey, Kenneth W ; Moryusef, Angele ; Pordy, Robert ; Roe, Matthew T ; Sritara, Piyamitr ; Tricoci, Pierluigi ; Zeiher, Andreas M ; Schwartz, Gregory G

European heart journal, 2019-09, Vol.40 (33), p.2801-2809 [Periódico revisado por pares]

England: Oxford University Press

Texto completo disponível

Citações Citado por
24
Apixaban vs. warfarin with concomitant aspirin in patients with atrial fibrillation: insights from the ARISTOTLE trial
Apixaban vs. warfarin with concomitant aspirin in patients with atrial fibrillation: insights from the ARISTOTLE trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Apixaban vs. warfarin with concomitant aspirin in patients with atrial fibrillation: insights from the ARISTOTLE trial

Alexander, John H ; Lopes, Renato D ; Thomas, Laine ; Alings, Marco ; Atar, Dan ; Aylward, Philip ; Goto, Shinya ; Hanna, Michael ; Huber, Kurt ; Husted, Steen ; Lewis, Basil S ; McMurray, John J V ; Pais, Prem ; Pouleur, Hubert ; Steg, Philippe Gabriel ; Verheugt, Freek W A ; Wojdyla, Daniel M ; Granger, Christopher B ; Wallentin, Lars

European heart journal, 2014-01, Vol.35 (4), p.224-232 [Periódico revisado por pares]

England

Texto completo disponível

Citações Citado por
25
A biomarker-based risk score to predict death in patients with atrial fibrillation: the ABC (age, biomarkers, clinical history) death risk score
A biomarker-based risk score to predict death in patients with atrial fibrillation: the ABC (age, biomarkers, clinical history) death risk score
Material Type:
Artigo 		Adicionar ao Meu Espaço

A biomarker-based risk score to predict death in patients with atrial fibrillation: the ABC (age, biomarkers, clinical history) death risk score

Hijazi, Ziad ; Oldgren, Jonas ; Lindbäck, Johan ; Alexander, John H ; Connolly, Stuart J ; Eikelboom, John W ; Ezekowitz, Michael D ; Held, Claes ; Hylek, Elaine M ; Lopes, Renato D ; Yusuf, Salim ; Granger, Christopher B ; Siegbahn, Agneta ; Wallentin, Lars

European heart journal, 2018-02, Vol.39 (6), p.477-485 [Periódico revisado por pares]

England: Oxford University Press

Texto completo disponível

Citações Citado por
26
The Cardiomyopathy Registry of the EURObservational Research Programme of the European Society of Cardiology: baseline data and contemporary management of adult patients with cardiomyopathies
The Cardiomyopathy Registry of the EURObservational Research Programme of the European Society of Cardiology: baseline data and contemporary management of adult patients with cardiomyopathies
Material Type:
Artigo 		Adicionar ao Meu Espaço

The Cardiomyopathy Registry of the EURObservational Research Programme of the European Society of Cardiology: baseline data and contemporary management of adult patients with cardiomyopathies

Charron, Philippe ; Elliott, Perry M ; Gimeno, Juan R ; Caforio, Alida L P ; Kaski, Juan Pablo ; Tavazzi, Luigi ; Tendera, Michal ; Maupain, Carole ; Laroche, Cécile ; Rubis, Pawel ; Jurcut, Ruxandra ; Calò, Leonardo ; Heliö, Tiina M ; Sinagra, Gianfranco ; Zdravkovic, Marija ; Kavoliūnienė, Aušra ; Felix, Stephan B ; Grzybowski, Jacek ; Losi, Maria-Angela ; Asselbergs, Folkert W ; García-Pinilla, José Manuel ; Salazar-Mendiguchia, Joel ; Mizia-Stec, Katarzyna ; Maggioni, Aldo P

European heart journal, 2018-05, Vol.39 (20), p.1784-1793 [Periódico revisado por pares]

England: Oxford University Press

Texto completo disponível

Citações Citado por
27
Alpha-protein kinase 3 (ALPK3) truncating variants are a cause of autosomal dominant hypertrophic cardiomyopathy
Alpha-protein kinase 3 (ALPK3) truncating variants are a cause of autosomal dominant hypertrophic cardiomyopathy
Material Type:
Artigo 		Adicionar ao Meu Espaço

Alpha-protein kinase 3 (ALPK3) truncating variants are a cause of autosomal dominant hypertrophic cardiomyopathy

Lopes, Luis R ; Garcia-Hernández, Soledad ; Lorenzini, Massimiliano ; Futema, Marta ; Chumakova, Olga ; Zateyshchikov, Dmitry ; Isidoro-Garcia, Maria ; Villacorta, Eduardo ; Escobar-Lopez, Luis ; Garcia-Pavia, Pablo ; Bilbao, Raquel ; Dobarro, David ; Sandin-Fuentes, Maria ; Catalli, Claudio ; Gener Querol, Blanca ; Mezcua, Ainhoa ; Garcia Pinilla, Jose ; Bloch Rasmussen, Torsten ; Ferreira-Aguar, Ana ; Revilla-Martí, Pablo ; Basurte Elorz, Maria Teresa ; Bautista Paves, Alicia ; Ramon Gimeno, Juan ; Figueroa, Ana Virginia ; Franco-Gutierrez, Raul ; Fuentes-Cañamero, Maria Eugenia ; Martinez Moreno, Marina ; Ortiz-Genga, Martin ; Piqueras-Flores, Jesus ; Analia Ramos, Karina ; Rudzitis, Ainars ; Ruiz-Guerrero, Luis ; Stein, Ricardo ; Triguero-Bocharán, Mayte ; de la Higuera, Luis ; Ochoa, Juan Pablo ; Abu-Bonsrah, Dad ; Kwok, Cecilia Y T ; Smith, Jacob B ; Porrello, Enzo R ; Akhtar, Mohammed M ; Jager, Joanna ; Ashworth, Michael ; Syrris, Petros ; Elliott, David A ; Monserrat, Lorenzo ; Elliott, Perry M

European heart journal, 2021-08, Vol.42 (32), p.3063-3073 [Periódico revisado por pares]

England: Oxford University Press

Texto completo disponível

Citações Citado por
28
Left ventricular myocardial and cavity velocity disturbances are stronger predictors of stress induced ischaemia in patients with significant coronary artery disease
Left ventricular myocardial and cavity velocity disturbances are stronger predictors of stress induced ischaemia in patients with significant coronary artery disease
Material Type:
Artigo 		Adicionar ao Meu Espaço

Left ventricular myocardial and cavity velocity disturbances are stronger predictors of stress induced ischaemia in patients with significant coronary artery disease

Bytyci, I ; Alves, L ; Lopes, L ; Henein, M Y

European heart journal, 2022-10, Vol.43 (Supplement_2) [Periódico revisado por pares]

Texto completo disponível

Citações Citado por
29
Late gadolinium enhancement is a strong predictor of life threatening arrhythmias in patients with dilated cardiomyopathy undergoing ICD implantation for primary prevention of sudden cardiac death
Late gadolinium enhancement is a strong predictor of life threatening arrhythmias in patients with dilated cardiomyopathy undergoing ICD implantation for primary prevention of sudden cardiac death
Material Type:
Artigo 		Adicionar ao Meu Espaço

Late gadolinium enhancement is a strong predictor of life threatening arrhythmias in patients with dilated cardiomyopathy undergoing ICD implantation for primary prevention of sudden cardiac death

Lopes Da Cunha, G J ; Lopes, P ; Freitas, P ; Rocha, B ; Gomes, D ; Paiva, M ; Amador, R ; Abecasis, J ; Guerreiro, S ; Matos, D ; Rodrigues, G ; Carvalho, M S ; Mendes, M ; Adragao, P ; Ferreira, A

European heart journal, 2022-10, Vol.43 (Supplement_2) [Periódico revisado por pares]

Texto completo disponível

Citações Citado por
30
Mitral annulus disjunction: a detailed magnetic resonance study of phenotype and clinical significance
Mitral annulus disjunction: a detailed magnetic resonance study of phenotype and clinical significance
Material Type:
Artigo 		Adicionar ao Meu Espaço

Mitral annulus disjunction: a detailed magnetic resonance study of phenotype and clinical significance

Custodio, P M ; Campos, P ; Moura, A R ; Khanji, M ; Bicho, J A ; Lopes, L R

European heart journal, 2023-11, Vol.44 (Supplement_2) [Periódico revisado por pares]

US: Oxford University Press

Texto completo disponível

Citações Citado por
previous page 1 2 Resultados 3 4 5 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Data de Publicação 

De até
Refinar
  1. Antes de1999  (3)
  2. 1999Até2011  (7)
  3. 2012Até2014  (23)
  4. 2015Até2018  (35)
  5. Após 2018  (116)
  6. Mais opções open sub menu

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.